Benzinga's Top #PreMarket Losers
May 02, 2014 at 08:53 AM EDT
Endocyte (NASDAQ: ECYT) shares fell 61.16% to $6.75 in pre-market trading after the company reported first quarter financial results and ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.